Peerbridge Bets On At-Home Heart Monitoring With Rechargeable, Longer-Lasting ECG Patch

Peerbridge Health is preparing to submit its next-generation ECG patch, CorMDx, for US FDA clearance this quarter, with plans to launch in the second half of 2025. The rechargeable device is designed for continuous, real-time heart monitoring from the hospital to home, aiming to detect early signs of heart failure and reduce emergency room visits.

(Peerbridge)

Peerbridge CEO Chris Darland has high hopes that the company’s second-generation ECG wireless patch CorMDx will eventually make its way into patients’ homes to allow for continuous heart monitoring as a way to promote early intervention, reduce hospital visits and save lives.

The company plans to submit the device for US Food and Drug Administration clearance this quarter and, pending regulatory clearance,...

More from Clinical Trials

More from Leadership